HIF1A and breast cancer: Later studies have corroborated a significant enrichment in cell populations exhibiting stem like and EMT phenotypes after exposure to hypoxia [49], [50] and very recently, Conley et al [51] have proposed that tumor hypoxia secondary to antiangiogenic therapy in breast cancer limits its effectiveness, as it stimulates stem-like cell enrichment through HIF1-driven EMT.